Thursday, November 14, 2019
Breaking Medical Device Industry News
Home ACEA Biosciences

ACEA Biosciences

    Bacterial Biofilm Infections: Personalizing Patient Treatment Using xCELLigence Assays

    Research scientists and physicians aim to use real-time cell analysis instruments to quickly characterize, ex vivo, the antibiotic susceptibility of bacterial biofilm infections prior...

    Cancer and Immunotherapy Symposium Hosted by ACEA Biosciences Gathers Clinicians and Scientists From Around the World

    Researchers from academia, industry, and federal agencies convened in Washington, D.C. this week to discuss recent progress in diverse areas of basic and applied...

    RECENT COMMENTS